ATXS
Price
$12.45
Change
-$0.04 (-0.32%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
713.28M
106 days until earnings call
Intraday BUY SELL Signals
COYA
Price
$5.77
Change
-$0.39 (-6.33%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
127.76M
Intraday BUY SELL Signals
Interact to see
Advertisement

ATXS vs COYA

Header iconATXS vs COYA Comparison
Open Charts ATXS vs COYABanner chart's image
Astria Therapeutics
Price$12.45
Change-$0.04 (-0.32%)
Volume$6.12K
Capitalization713.28M
Coya Therapeutics
Price$5.77
Change-$0.39 (-6.33%)
Volume$7.88K
Capitalization127.76M
ATXS vs COYA Comparison Chart in %
ATXS
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATXS vs. COYA commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and COYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ATXS: $12.49 vs. COYA: $6.11)
Brand notoriety: ATXS and COYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 31% vs. COYA: 77%
Market capitalization -- ATXS: $710.14M vs. COYA: $121.15M
ATXS [@Biotechnology] is valued at $710.14M. COYA’s [@Biotechnology] market capitalization is $121.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCOYA’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • COYA’s FA Score: 0 green, 5 red.
According to our system of comparison, COYA is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while COYA’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 5 bearish.
  • COYA’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than COYA.

Price Growth

ATXS (@Biotechnology) experienced а -0.12% price change this week, while COYA (@Biotechnology) price change was +1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($713M) has a higher market cap than COYA($128M). ATXS YTD gains are higher at: 39.765 vs. COYA (6.562). COYA has higher annual earnings (EBITDA): -22.59M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. COYA (29.8M). COYA has higher revenues than ATXS: COYA (423K) vs ATXS (0).
ATXSCOYAATXS / COYA
Capitalization713M128M557%
EBITDA-131.42M-22.59M582%
Gain YTD39.7656.562606%
P/E RatioN/AN/A-
Revenue0423K-
Total Cash259M29.8M869%
Total Debt4.77MN/A-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCOYA
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 6 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 8 days ago
89%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signal:
Gain/Loss:
COYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVRX43.960.38
+0.87%
Columbia Small Cap Value Discv R
CMGSX35.90N/A
N/A
BlackRock Mid-Cap Growth Equity Svc
JMIGX32.59N/A
N/A
Jacob Discovery Fd Instl
POICX11.29N/A
N/A
Virtus Tactical Allocation C
GINNX65.65-0.39
-0.59%
Guinness Atkinson™ Global Inntrs Instl

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-0.60%
XENE - ATXS
49%
Loosely correlated
N/A
SYRE - ATXS
49%
Loosely correlated
-1.07%
RGNX - ATXS
48%
Loosely correlated
+0.94%
ORKA - ATXS
46%
Loosely correlated
-2.76%
CRNX - ATXS
45%
Loosely correlated
-1.17%
More

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+4.38%
GANX - COYA
42%
Loosely correlated
+0.90%
KNSA - COYA
42%
Loosely correlated
-0.29%
ATXS - COYA
40%
Loosely correlated
-0.60%
TRDA - COYA
36%
Loosely correlated
+4.25%
IRON - COYA
36%
Loosely correlated
+0.10%
More